Cookie Policy: This site uses cookies to improve your experience. You can find out more about our use of cookies in our Privacy Policy. By continuing to browse this site you agree to our use of cookies.
AdipoGen Life Sciences
bpV(phen)
65
CHF
CHF 65.00
In stock
AG-CR1-0042-M0055 mgCHF 65.00
AG-CR1-0042-M02525 mgCHF 240.00
| Product Details | |
|---|---|
| Synonyms | Potassium bisperoxo (1,10-phenanthroline) oxovanadate (V) |
| Product Type | Chemical |
| Properties | |
| Formula |
K[VO(O2)2C12H8N2] . 3H2O |
| MW | 350.2 . 54.0 |
| CAS | 171202-16-7 |
| Purity Chemicals | ≥99% (51V-NMR) |
| Appearance | Yellow to orange crystalline solid. |
| Solubility | Soluble in DMSO (1mg/ml) or water (10mg/ml). |
| Identity | Determined by 51V-NMR (D2O). |
| InChi Key | PKEQYULPAHCPOP-UHFFFAOYSA-N |
| Smiles | C1[N]2=CC=CC3=C2C2=[N]1C=CC=C2C=C3 |
| Shipping and Handling | |
| Shipping | AMBIENT |
| Short Term Storage | +4°C |
| Long Term Storage | -20°C |
| Handling Advice | Protect from light. |
| Use/Stability | Stable for at least 2 years after receipt when stored at -20°C. |
| Documents | |
| MSDS |
 Download PDF |
| Product Specification Sheet | |
| Datasheet |
Download PDF |
Description
- Potent protein phosphotyrosine phosphatase inhibitor [1, 2, 5].
- Insulin receptor kinase (IRK) inducer [2].
- Insulin mimetic in vitro and in vivo [3, 4].
- Apoptosis inducer [6].
- ERK inducer [7].
- Mitogen-activated protein kinase phosphatase-1 (MKP-1) inducer [7].
- Angiogenesis inhibitor [8].
- PTEN inhibitor [9].
Product References
- Peroxovanadium compounds. A new class of potent phosphotyrosine phosphatase inhibitors which are insulin mimetics: B.I. Posner, et al.; J. Biol. Chem. 269, 4596 (1994)
- Early signaling events triggered by peroxovanadium [bpV(phen)] are insulin receptor kinase (IRK)-dependent: specificity of inhibition of IRK-associated protein tyrosine phosphatase(s) by bpV(phen): C.J. Band, et al.; Mol. Endocrinol. 11, 1899 (1997)
- Hypoglycemic effects of peroxovanadium compounds in Sprague-Dawley and diabetic BB rats: J.F. Yale, et al.; Diabetes 44, 1274 (1995)
- In vivo insulin mimetic effects of pV compounds: role for tissue targeting in determining potency: A.P. Bevan, et al.; Am. J. Physiol. 268, E60 (1995)
- A role for tyrosine phosphorylation in both activation and inhibition of the insulin receptor tyrosine kinase in vivo: P.G. Drake, et al.; Endocrinology 137, 4960 (1996)
- BpV (phen) induces apoptosis of RINm5F cells by modulation of MAPKs and MKP-1: L. Rumora, et al.; BBRC 300, 877 (2003)
- Positive regulation of ERK activation and MKP-1 expression by peroxovanadium complex bpV (phen): L. Rumora, et al.; Cell Biol. Toxicol. 20, 293 (2004)
- Peroxovanadium compounds as inhibitors of angiogenesis: C. J. Doillon, et al.; Angiogenesis 3, 361 (1999)
- Bisperoxovanadium compounds are potent PTEN inhibitors: A.C. Schmid, et al.; FEBS Lett. 566, 35 (2004)
Related Products
